Could cause temporary or reversible harm; serious harm is unlikely.
CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.
| Distributed by / for | Bi-Coastal Pharma International, Shrewsbury, NJ |
| NDC | 42582-111-18 |
| Full product label | Ibuprofen Tablets USP 400 mg, 500 tablet bottles (NDC 42582-111-18), Rx, Distributed by Bi-Coastal Pharma International, Shrewsbury, NJ, Manufactured by: Marksans Pharma, Ltd., Plot No. L-82, L-83 Verna indl. Estate Verna, Goa-403 722, India |
| Recalling firm | Time-Cap Laboratories, Inc. |
| Distribution | Nationwide. |
| Quantity | N/A |
| Recall initiated | 2018-01-11 |
| Report date | 2018-05-02 |
| Recall completed | 2021-01-20 |
| Recall number | D-0688-2018 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Farmingdale NY United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗